[go: up one dir, main page]

AR017197A1 - Formulacion de hidrogel farmaceutica, dispositivos de suministro de droga, metodo para eliminar sineresis, y metodos para preparar formulaciones farmaceuticas. - Google Patents

Formulacion de hidrogel farmaceutica, dispositivos de suministro de droga, metodo para eliminar sineresis, y metodos para preparar formulaciones farmaceuticas.

Info

Publication number
AR017197A1
AR017197A1 ARP980106205A ARP980106205A AR017197A1 AR 017197 A1 AR017197 A1 AR 017197A1 AR P980106205 A ARP980106205 A AR P980106205A AR P980106205 A ARP980106205 A AR P980106205A AR 017197 A1 AR017197 A1 AR 017197A1
Authority
AR
Argentina
Prior art keywords
formulation
pharmaceutical
methods
formulations
supply devices
Prior art date
Application number
ARP980106205A
Other languages
English (en)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of AR017197A1 publication Critical patent/AR017197A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una formulacion de hidrogel farmacéutico, disposicion de suministro de droga, dispositivo de suministro de droga por electro transporte, método paraeliminar sinéresis, método para hacer una formulacion de hidrogel farmacéutico, método para hacer unaformulacion de formulacion farmacéuticaconteniendo alcohol de polivinilo. Las formulaciones pueden servir como depositos de droga en disposiciones de suministros de droga por electrotransporteo disposiciones transdérmicas pasivas, o pueden serusadas en una variedad de tipos de formas de dosificacion, por ejemplo, cápsulas, supositorios,aerosoles y similares. Con estas formulaciones, virtualmente no se ha encontrado sinéresis luego de almacenamiento de largo plazo, una ventaja queprovienede sel eccionar la cantidad de alcohol de polivinilo en el gel para corresponder al grado de hidrolisis del polímero.
ARP980106205A 1997-12-09 1998-12-07 Formulacion de hidrogel farmaceutica, dispositivos de suministro de droga, metodo para eliminar sineresis, y metodos para preparar formulaciones farmaceuticas. AR017197A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/987,372 US6039977A (en) 1997-12-09 1997-12-09 Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods

Publications (1)

Publication Number Publication Date
AR017197A1 true AR017197A1 (es) 2001-08-22

Family

ID=25533223

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980106205A AR017197A1 (es) 1997-12-09 1998-12-07 Formulacion de hidrogel farmaceutica, dispositivos de suministro de droga, metodo para eliminar sineresis, y metodos para preparar formulaciones farmaceuticas.

Country Status (16)

Country Link
US (1) US6039977A (es)
EP (1) EP1037667B1 (es)
JP (1) JP2001525377A (es)
KR (1) KR100568482B1 (es)
CN (1) CN1147319C (es)
AR (1) AR017197A1 (es)
AT (1) ATE266422T1 (es)
AU (1) AU1535799A (es)
CA (1) CA2313642C (es)
DE (1) DE69823869T2 (es)
DK (1) DK1037667T3 (es)
ES (1) ES2221228T3 (es)
PT (1) PT1037667E (es)
TW (1) TWI231214B (es)
WO (1) WO1999029348A1 (es)
ZA (1) ZA9810641B (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
GB0005016D0 (en) * 2000-03-01 2000-04-26 Jumik Technologies Limited PVA-Containing compositions
US6992065B2 (en) 2000-04-19 2006-01-31 Genentech, Inc. Sustained release formulations
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
IL157531A0 (en) * 2001-02-23 2004-03-28 Genentech Inc Erodible polymers for injection
JP4320177B2 (ja) * 2001-04-04 2009-08-26 アルザ・コーポレーシヨン 抗微生物適合性レザバー組成物を含む経皮性電気輸送デリバリー装置
IL159048A0 (en) * 2001-06-21 2004-05-12 Genentech Inc Sustained release formulation
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
ITMI20012060A1 (it) * 2001-10-05 2003-04-05 Recordati Chem Pharm Nuovi eterocilcli n-acilati
WO2003046144A2 (en) * 2001-11-26 2003-06-05 Molecular Reflections, Inc. Microscale immobilization of molecules using a hydrogel and methods of use thereof
CA2512854C (en) * 2002-06-28 2010-02-09 Alza Corporation A reservoir for use in electrotransport drug delivery
US20040158194A1 (en) * 2003-02-06 2004-08-12 Wolff Andy And Beiski Ben Z. Oral devices and methods for controlled drug release
WO2005051485A1 (en) * 2003-11-19 2005-06-09 Alza Corporation Peptidically buffered formulations for electrotransport applications and methods of making
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch
CN100386073C (zh) * 2004-03-03 2008-05-07 杭州民生药业集团有限公司 一种经皮给药系统
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
WO2006055729A1 (en) * 2004-11-16 2006-05-26 Transcutaneous Technologies Inc. Iontophoretic device and method for administering immune response-enhancing agents and compositions
US20070106138A1 (en) * 2005-05-26 2007-05-10 Beiski Ben Z Intraoral apparatus for non-invasive blood and saliva monitoring & sensing
WO2006133101A2 (en) * 2005-06-03 2006-12-14 Trans-Dermal Patents Company, Llc Agent delivery system
US20090143761A1 (en) * 2005-06-03 2009-06-04 Transdermal Patents Company, Llc Agent delivery system and uses of same
US20090214625A1 (en) * 2005-07-15 2009-08-27 Mizuo Nakayama Drug delivery patch
JP4969812B2 (ja) * 2005-07-22 2012-07-04 久光製薬株式会社 ハイドロゲル組成物
CA2621234A1 (en) 2005-08-31 2007-03-08 Alza Corporation Cathode for electrotransport delivery of anionic drug
US20070078375A1 (en) * 2005-09-30 2007-04-05 Transcutaneous Technologies Inc. Iontophoretic delivery of active agents conjugated to nanoparticles
US7848801B2 (en) 2005-12-30 2010-12-07 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
EP2001547A2 (en) * 2006-03-21 2008-12-17 ALZA Corporation Hydratable polymeric ester matrix for drug electrotransport
US8246973B2 (en) * 2006-06-21 2012-08-21 Advanced Cardiovascular Systems, Inc. Freeze-thaw method for modifying stent coating
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
JP2010502270A (ja) * 2006-08-29 2010-01-28 アルザ・コーポレーシヨン 水和可能な貯蔵器の水和測定付きの薬品電気輸送
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
EP2101864A2 (en) 2006-12-20 2009-09-23 ALZA Corporation Anode for electrotransport of cationic drug
JPWO2008087803A1 (ja) * 2007-01-16 2010-05-06 国立大学法人北海道大学 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
WO2008116105A1 (en) * 2007-03-22 2008-09-25 Alza Corporation Pivotally engaged multiple part electrotransport drug delivery device
KR20100020008A (ko) * 2007-05-18 2010-02-19 티티아이 엘뷰 가부시키가이샤 생물학적 인터페이스를 통한 활성 성분의 방출을 개선한 경피 전달 장치
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
US20090043244A1 (en) * 2007-08-08 2009-02-12 Inan Omer T Electrotransport Drug Delivery Device Adaptable to Skin Resistance Change
US20090105634A1 (en) * 2007-10-17 2009-04-23 Alza Corporation Anodic Reservoir for Electrotransport of Cationic Drug
US20090105632A1 (en) * 2007-10-18 2009-04-23 Padmanabhan Rama V Electrotransport Of Lisuride
USD588274S1 (en) 2008-02-12 2009-03-10 Alza Corporation Skin-adhering drug delivery patch
US20090312689A1 (en) * 2008-06-05 2009-12-17 Alza Corporation Adjustable Current Electrotransport Fentanyl Delivery Device
CA2736495A1 (en) * 2008-09-10 2010-03-18 Gregory A. Smith Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process
US8048442B1 (en) 2008-09-16 2011-11-01 Abbott Cardiovascular Systems Inc. Modified heparin-based coatings and related drug eluting stents
US8301238B2 (en) 2011-03-31 2012-10-30 Incline Therapeutics, Inc. Two-part electrotransport device
US8428708B1 (en) 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
USD699855S1 (en) 2012-11-12 2014-02-18 Incline Therapeutics, Inc. Iontophoretic drug delivery device
US9855211B2 (en) * 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US10478498B2 (en) 2014-06-20 2019-11-19 Reform Biologics, Llc Excipient compounds for biopolymer formulations
GB2533827B (en) * 2015-05-21 2016-12-21 Gateway Devices Ltd Intravenous access device
US20170136180A1 (en) * 2015-09-25 2017-05-18 Massachusetts Institute Of Technology Stretchable, Robust and Biocompatible Hydrogel Electronics and Devices
EP3484520A4 (en) 2016-07-13 2020-07-29 Reform Biologics, LLC STABILIZING EXCIPIENTS FOR THERAPEUTIC PROTEIN FORMULATIONS
CN106491517B (zh) * 2016-11-23 2019-12-06 佛山科学技术学院 吡非尼酮pva水凝胶的制备方法及吡非尼酮pva水凝胶
CN116439678A (zh) * 2023-03-30 2023-07-18 香港心脑血管健康工程研究中心有限公司 一种基于动脉血压图的高血压实时监测和闭环给药装置
CN116570553A (zh) * 2023-05-25 2023-08-11 上海交通大学医学院附属第九人民医院 一种载药导电凝胶、其制备方法及其在离子导入技术中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3265697D1 (en) * 1981-02-05 1985-10-03 Nippon Oil Co Ltd Process for preparing a hydrogel
DE3278911D1 (en) * 1981-05-16 1988-09-22 Nippon Oil Co Ltd Process for the preparation of gel for use as cooling medium
US4542013A (en) * 1981-07-08 1985-09-17 Key Pharmaceuticals, Inc. Trinitroglycerol sustained release vehicles and preparation therefrom
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
JPS61218517A (ja) * 1985-03-25 1986-09-29 Bio Materiaru Yunibaasu:Kk 経皮吸収製剤
EP0303445A1 (en) * 1987-08-13 1989-02-15 Walton S.A. Clebopride transdermal patch
JPH0720544B2 (ja) * 1988-12-27 1995-03-08 日本石油株式会社 Ｐｖａヒドロゲルの製造法及びｍｒｉファントム
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
EP0516026A1 (en) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel and method of producing same
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
AU3938797A (en) * 1996-08-29 1998-03-19 Novo Nordisk A/S Transdermal delivery of peptides
US6650934B2 (en) * 1996-12-17 2003-11-18 Alza Corp Polymeric foam reservoirs for an electrotransport delivery device

Also Published As

Publication number Publication date
WO1999029348A1 (en) 1999-06-17
KR100568482B1 (ko) 2006-04-07
TWI231214B (en) 2005-04-21
AU1535799A (en) 1999-06-28
DE69823869T2 (de) 2005-05-19
CA2313642A1 (en) 1999-06-17
CA2313642C (en) 2008-09-30
DK1037667T3 (da) 2004-09-20
EP1037667B1 (en) 2004-05-12
ZA9810641B (en) 1999-05-24
JP2001525377A (ja) 2001-12-11
KR20010032839A (ko) 2001-04-25
EP1037667A1 (en) 2000-09-27
CN1147319C (zh) 2004-04-28
CN1281372A (zh) 2001-01-24
US6039977A (en) 2000-03-21
ATE266422T1 (de) 2004-05-15
PT1037667E (pt) 2004-08-31
DE69823869D1 (de) 2004-06-17
ES2221228T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
AR017197A1 (es) Formulacion de hidrogel farmaceutica, dispositivos de suministro de droga, metodo para eliminar sineresis, y metodos para preparar formulaciones farmaceuticas.
ES2031597T3 (es) Aparato distribuidor con un miembro dispensador para entregar un agente beneficioso.
ES2271775T3 (es) Un deposito - electrodo de iontoforesis y un metodo para preparar una unidad deposito - electrodo cargada.
ES2672239T3 (es) Reducción mejorada del dolor en el lugar de infusión para dispositivos de administración de fármacos
AR046922A1 (es) Sistema y metodo para la administracion transdermica de vacunas.
GB2440039A (en) Devices, systems and methods for medicament delivery
ES2180251T3 (es) Comprimido revestido con polimero, que contiene amoxicilina y clavulanato.
CR20130201A (es) Dispositivos para suministrar un medicamento y método para aliviar el dolor
WO2006042297A3 (en) Device and method for generating an aerosol from a liquid formulation and ensuring its sterility
FI914607A0 (fi) Farmaceutisk blandning i gelform i en dispenserfoerpackning.
MXPA00008174A (es) Mejoras en los dispositivos de distribucion de medicamento.
ECSP088342A (es) Dispositivo dispensador, dispositivo de almacenamiento y método para dispensar una formulacion
AR024966A1 (es) Formulacion farmaceutica
ES2116006T3 (es) Envase dispensador para pilas de hojas.
AR040024A1 (es) Procedimiento para introducir una dosis de un componente liquido en un recipiente y aparato para la introduccion de dicho liquido en el recipiente
AR105798A2 (es) Preparaciones farmacéuticas para la aplicación oral, que contienen resinas intercambiadoras de iones cargadas con el producto activo, así como formadores de gel intrínsicamente viscosos a modo de espesantes
ES2031238T3 (es) Aparato distribuidor con matriz movil que incluye una pluralidad de pildoras de tamano reducido.
ATE210474T1 (de) Implantierbare vorrichtung zur arzneiabgabe
CR7921A (es) Formulaciones farmaceuticas liquidas de palonosetron
ES2183841T3 (es) Formas de dosificacion para administrar un farmasco en una formulacion lquidid.
AR019145A1 (es) Proceso para aplicar un estrato a una unidad farmaceutica, forma de dosis de unidad, y aparato para estratificar una unidad farmaceutica.
CO5011082A1 (es) Formulacion medicamentosa con liberacion controlada de sus- tancia activa
PT1178854E (pt) Dispositivo para administracao transcutanea de moleculas contidas num produto transportador relativamente viscoso, tal como um gel ou semelhante
ES2087407T3 (es) Derivados de cromano sustituido con piperidilmetilo como principio activo para el tratamiento de enfermedades del sistema nervioso central.
ES2118726T3 (es) Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.

Legal Events

Date Code Title Description
FG Grant, registration